Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 41

1.

A Novel t(8;14)(q24;q11) Rearranged Human Cell Line as a Model for Mechanistic and Drug Discovery Studies of NOTCH1-Independent Human T-Cell Leukemia.

Tosello V, Milani G, Martines A, Macri N, Van Loocke W, Matthijssens F, Buldini B, Minuzzo S, Bongiovanni D, Schumacher RF, Amadori A, Van Vlierberghe P, Piovan E.

Cells. 2018 Oct 9;7(10). pii: E160. doi: 10.3390/cells7100160.

2.

Selective killing of human T-ALL cells: an integrated approach targeting redox homeostasis and the OMA1/OPA1 axis.

Silic-Benussi M, Scattolin G, Cavallari I, Minuzzo S, Del Bianco P, Francescato S, Basso G, Indraccolo S, D'Agostino DM, Ciminale V.

Cell Death Dis. 2018 Aug 1;9(8):822. doi: 10.1038/s41419-018-0870-9.

3.

Histone deacetylase 6 controls Notch3 trafficking and degradation in T-cell acute lymphoblastic leukemia cells.

Pinazza M, Ghisi M, Minuzzo S, Agnusdei V, Fossati G, Ciminale V, Pezzè L, Ciribilli Y, Pilotto G, Venturoli C, Amadori A, Indraccolo S.

Oncogene. 2018 Jul;37(28):3839-3851. doi: 10.1038/s41388-018-0234-z. Epub 2018 Apr 12.

4.

AKR1C enzymes sustain therapy resistance in paediatric T-ALL.

Bortolozzi R, Bresolin S, Rampazzo E, Paganin M, Maule F, Mariotto E, Boso D, Minuzzo S, Agnusdei V, Viola G, Te Kronnie G, Cazzaniga G, Basso G, Persano L.

Br J Cancer. 2018 Apr;118(7):985-994. doi: 10.1038/s41416-018-0014-0. Epub 2018 Mar 8.

PMID:
29515258
5.

WT1 loss attenuates the TP53-induced DNA damage response in T-cell acute lymphoblastic leukemia.

Bordin F, Piovan E, Masiero E, Ambesi-Impiombato A, Minuzzo S, Bertorelle R, Sacchetto V, Pilotto G, Basso G, Zanovello P, Amadori A, Tosello V.

Haematologica. 2018 Feb;103(2):266-277. doi: 10.3324/haematol.2017.170431. Epub 2017 Nov 23.

6.

Glucocorticoid resistance is reverted by LCK inhibition in pediatric T-cell acute lymphoblastic leukemia.

Serafin V, Capuzzo G, Milani G, Minuzzo SA, Pinazza M, Bortolozzi R, Bresolin S, Porcù E, Frasson C, Indraccolo S, Basso G, Accordi B.

Blood. 2017 Dec 21;130(25):2750-2761. doi: 10.1182/blood-2017-05-784603. Epub 2017 Nov 3.

7.

Variables of Individual Difference and the Experience of Touch in Nursing.

Pedrazza M, Berlanda S, Trifiletti E, Minuzzo S.

West J Nurs Res. 2018 Nov;40(11):1614-1637. doi: 10.1177/0193945917705621. Epub 2017 Apr 30.

PMID:
28459179
8.

ZNF521 sustains the differentiation block in MLL-rearranged acute myeloid leukemia.

Germano G, Morello G, Aveic S, Pinazza M, Minuzzo S, Frasson C, Persano L, Bonvini P, Viola G, Bresolin S, Tregnago C, Paganin M, Pigazzi M, Indraccolo S, Basso G.

Oncotarget. 2017 Apr 18;8(16):26129-26141. doi: 10.18632/oncotarget.15387.

9.

STR Profiling of HTLV-1-Infected Cell Lines.

Raimondi V, Minuzzo S, Ciminale V, D'Agostino DM.

Methods Mol Biol. 2017;1582:143-154. doi: 10.1007/978-1-4939-6872-5_11.

PMID:
28357668
10.

NUP98-fusion transcripts characterize different biological entities within acute myeloid leukemia: a report from the AIEOP-AML group.

Bisio V, Zampini M, Tregnago C, Manara E, Salsi V, Di Meglio A, Masetti R, Togni M, Di Giacomo D, Minuzzo S, Leszl A, Zappavigna V, Rondelli R, Mecucci C, Pession A, Locatelli F, Basso G, Pigazzi M.

Leukemia. 2017 Apr;31(4):974-977. doi: 10.1038/leu.2016.361. Epub 2016 Nov 28. No abstract available.

PMID:
27890935
11.

An immediate transcriptional signature associated with response to the histone deacetylase inhibitor Givinostat in T acute lymphoblastic leukemia xenografts.

Pinazza M, Borga C, Agnusdei V, Minuzzo S, Fossati G, Paganin M, Michielotto B, De Paoli A, Basso G, Amadori A, te Kronnie G, Indraccolo S.

Cell Death Dis. 2016 Jan 14;6:e2047. doi: 10.1038/cddis.2015.394.

12.

Development and Initial Validation of the Nurses' Comfort With Touch Scale.

Pedrazza M, Trifiletti E, Berlanda S, Minuzzo S, Motteran A.

J Nurs Meas. 2015;23(3):364-78. doi: 10.1891/1061-3749.23.3.364.

PMID:
26673764
13.

DLL4 regulates NOTCH signaling and growth of T acute lymphoblastic leukemia cells in NOD/SCID mice.

Minuzzo S, Agnusdei V, Pusceddu I, Pinazza M, Moserle L, Masiero M, Rossi E, Crescenzi M, Hoey T, Ponzoni M, Amadori A, Indraccolo S.

Carcinogenesis. 2015 Jan;36(1):115-21. doi: 10.1093/carcin/bgu223. Epub 2014 Oct 29.

PMID:
25355291
14.

Nurses' comfort with touch and workplace well-being.

Pedrazza M, Minuzzo S, Berlanda S, Trifiletti E.

West J Nurs Res. 2015 Jun;37(6):781-98. doi: 10.1177/0193945914527356. Epub 2014 Mar 20.

PMID:
24658288
15.

Therapeutic antibody targeting of Notch1 in T-acute lymphoblastic leukemia xenografts.

Agnusdei V, Minuzzo S, Frasson C, Grassi A, Axelrod F, Satyal S, Gurney A, Hoey T, Seganfreddo E, Basso G, Valtorta S, Moresco RM, Amadori A, Indraccolo S.

Leukemia. 2014 Feb;28(2):278-88. doi: 10.1038/leu.2013.183. Epub 2013 Jun 18.

PMID:
23774673
16.

Notch3-mediated regulation of MKP-1 levels promotes survival of T acute lymphoblastic leukemia cells.

Masiero M, Minuzzo S, Pusceddu I, Moserle L, Persano L, Agnusdei V, Tosello V, Basso G, Amadori A, Indraccolo S.

Leukemia. 2011 Apr;25(4):588-98. doi: 10.1038/leu.2010.323. Epub 2011 Jan 25.

PMID:
21263446
17.

Ligand-driven activation of the notch pathway in T-ALL and solid tumors: why Not(ch)?

Indraccolo S, Minuzzo S, Masiero M, Amadori A.

Cell Cycle. 2010 Jan 1;9(1):80-5.

PMID:
20016278
18.

Cross-talk between tumor and endothelial cells involving the Notch3-Dll4 interaction marks escape from tumor dormancy.

Indraccolo S, Minuzzo S, Masiero M, Pusceddu I, Persano L, Moserle L, Reboldi A, Favaro E, Mecarozzi M, Di Mario G, Screpanti I, Ponzoni M, Doglioni C, Amadori A.

Cancer Res. 2009 Feb 15;69(4):1314-23. doi: 10.1158/0008-5472.CAN-08-2791. Epub 2009 Feb 10.

19.

The side population of ovarian cancer cells is a primary target of IFN-alpha antitumor effects.

Moserle L, Indraccolo S, Ghisi M, Frasson C, Fortunato E, Canevari S, Miotti S, Tosello V, Zamarchi R, Corradin A, Minuzzo S, Rossi E, Basso G, Amadori A.

Cancer Res. 2008 Jul 15;68(14):5658-68. doi: 10.1158/0008-5472.CAN-07-6341.

20.

Angiogenesis meets immunology: cytokine gene therapy of cancer.

Minuzzo S, Moserle L, Indraccolo S, Amadori A.

Mol Aspects Med. 2007 Feb;28(1):59-86. Epub 2007 Jan 11. Review.

PMID:
17306360
21.

Identification of genes selectively regulated by IFNs in endothelial cells.

Indraccolo S, Pfeffer U, Minuzzo S, Esposito G, Roni V, Mandruzzato S, Ferrari N, Anfosso L, Dell'Eva R, Noonan DM, Chieco-Bianchi L, Albini A, Amadori A.

J Immunol. 2007 Jan 15;178(2):1122-35.

22.

Interruption of tumor dormancy by a transient angiogenic burst within the tumor microenvironment.

Indraccolo S, Stievano L, Minuzzo S, Tosello V, Esposito G, Piovan E, Zamarchi R, Chieco-Bianchi L, Amadori A.

Proc Natl Acad Sci U S A. 2006 Mar 14;103(11):4216-21. Epub 2006 Mar 6.

23.

Gene therapy of ovarian cancer with IFN-alpha-producing fibroblasts: comparison of constitutive and inducible vectors.

Indraccolo S, Moserle L, Tisato V, Gola E, Minuzzo S, Roni V, Persano L, Chieco-Bianchi L, Amadori A.

Gene Ther. 2006 Jun;13(12):953-65. Epub 2006 Mar 2.

PMID:
16511522
24.
25.

CD40 activation of B-CLL cells is associated with augmented intracellular levels of CD79b and increased BCR expression in a subset of patients.

Minuzzo S, Indraccolo S, Tosello V, Piovan E, Cabrelle A, Trentin L, Semenzato G, Amadori A.

Leukemia. 2005 Jun;19(6):1099-101. No abstract available.

PMID:
15830006
26.

Alternatively spliced forms of Igalpha and Igbeta prevent B cell receptor expression on the cell surface.

Indraccolo S, Minuzzo S, Zamarchi R, Calderazzo F, Piovan E, Amadori A.

Eur J Immunol. 2002 Jun;32(6):1530-40.

27.

Differential effects of angiostatin, endostatin and interferon-alpha(1) gene transfer on in vivo growth of human breast cancer cells.

Indraccolo S, Gola E, Rosato A, Minuzzo S, Habeler W, Tisato V, Roni V, Esposito G, Morini M, Albini A, Noonan DM, Ferrantini M, Amadori A, Chieco-Bianchi L.

Gene Ther. 2002 Jul;9(13):867-78.

28.

Expression from cell type-specific enhancer-modified retroviral vectors after transduction: influence of marker gene stability.

Indraccolo S, Roni V, Zamarchi R, Roccaforte F, Minuzzo S, Stievano L, Habeler W, Marcato N, Tisato V, Tosello V, Chieco-Bianchi L, Amadori A.

Gene. 2002 Jan 23;283(1-2):199-208.

PMID:
11867226
29.

Effects of CD2 locus control region sequences on gene expression by retroviral and lentiviral vectors.

Indraccolo S, Minuzzo S, Roccaforte F, Zamarchi R, Habeler W, Stievano L, Tosello V, Klein D, Günzburg WH, Basso G, Chieco-Bianchi L, Amadori A.

Blood. 2001 Dec 15;98(13):3607-17.

30.

Modulation of Moloney leukemia virus long terminal repeat transcriptional activity by the murine CD4 silencer in retroviral vectors.

Indraccolo S, Minuzzo S, Habeler W, Zamarchi R, Fregonese A, Günzburg WH, Salmons B, Uckert W, Chieco-Bianchi L, Amadori A.

Virology. 2000 Oct 10;276(1):83-92.

31.

Generation of expression plasmids for angiostatin, endostatin and TIMP-2 for cancer gene therapy.

Indraccolo S, Minuzzo S, Gola E, Habeler W, Carrozzino F, Noonan D, Albini A, Santi L, Amadori A, Chieco-Bianchi L.

Int J Biol Markers. 1999 Oct-Dec;14(4):251-6.

PMID:
10669955
32.

Mutator phenotype in human hematopoietic neoplasms and its association with deletions disabling DNA repair genes and bcl-2 rearrangements.

Indraccolo S, Minuzzo S, Nicoletti L, Cretella E, Simon M, Papakonstantinou G, Hehlmann R, Mion M, Bertorelle R, Roganovic J, Chieco-Bianchi L.

Blood. 1999 Oct 1;94(7):2424-32.

33.

An alternatively spliced form of CD79b gene may account for altered B-cell receptor expression in B-chronic lymphocytic leukemia.

Alfarano A, Indraccolo S, Circosta P, Minuzzo S, Vallario A, Zamarchi R, Fregonese A, Calderazzo F, Faldella A, Aragno M, Camaschella C, Amadori A, Caligaris-Cappio F.

Blood. 1999 Apr 1;93(7):2327-35.

34.

Frequency of a mutated CCR-5 allele (delta32) among Italian healthy donors and individuals at risk of parenteral HIV infection.

Zamarchi R, Indraccolo S, Minuzzo S, Coppola V, Gringeri A, Santagostino E, Vicenzi E, De Silvestro G, Biagiotti R, Baldassarre C, Chieco-Bianchi L, Amadori A.

AIDS Res Hum Retroviruses. 1999 Mar 1;15(4):337-44.

PMID:
10082117
35.

Pseudotyping of Moloney leukemia virus-based retroviral vectors with simian immunodeficiency virus envelope leads to targeted infection of human CD4+ lymphoid cells.

Indraccolo S, Minuzzo S, Feroli F, Mammano F, Calderazzo F, Chieco-Bianchi L, Amadori A.

Gene Ther. 1998 Feb;5(2):209-17.

36.

Evolution of mitochondrial DNA in yeast: gene order and structural organization of the mitochondrial genome of Saccharomyces uvarum.

Cardazzo B, Minuzzo S, Sartori G, Grapputo A, Carignani G.

Curr Genet. 1998 Jan;33(1):52-9.

PMID:
9472080
37.

Lymphoproliferative disease in human peripheral blood mononuclear cell-injected SCID mice. IV. Differential activation of human Th1 and Th2 lymphocytes and influence of the atopic status on lymphoma development.

Coppola V, Veronesi A, Indraccolo S, Calderazzo F, Mion M, Minuzzo S, Esposito G, Mauro D, Silvestri B, Gallo P, Falagiani P, Amadori A, Chieco-Bianchi L.

J Immunol. 1998 Mar 1;160(5):2514-22.

38.

DNA immunization of mice against SIVmac239 Gag and Env using Rev-independent expression plasmids.

Indraccolo S, Feroli F, Minuzzo S, Mion M, Rosato A, Zamarchi R, Titti F, Verani P, Amadori A, Chieco-Bianchi L.

AIDS Res Hum Retroviruses. 1998 Jan 1;14(1):83-90.

PMID:
9453255
39.

TCR expression and clonality analysis in peripheral blood and lymph nodes of HIV-infected patients.

Mion M, Indraccolo S, Feroli F, Minuzzo S, Masiero S, Zamarchi R, Barelli A, Borri A, Chieco-Bianchi L, Amadori A.

Hum Immunol. 1997 Oct;57(2):93-103.

PMID:
9438200
40.

[The body and its meanings].

Minuzzo S, Guglielmi L.

Prof Inferm. 1996 Oct-Dec;49(4):27-30. Italian.

PMID:
9096040
41.

[Research on decubitus lesions: formation of a protocol].

Borroni A, Botticini ML, Di Giulio P, Ferrante L, Martinuzzi D, Minuzzo S, Ottone M, Redaelli A, Rossetti I, Sarani L, et al.

Riv Inferm. 1984 Jun;3(2):89-98. Italian. No abstract available.

PMID:
6438780

Supplemental Content

Loading ...
Support Center